Replies to post #45663 on Biotech Values

[DewDiligence]

Re: Proposed MS-treatment survey

>can you throw these other drugs in the mix?
Tysabri
Copaxone
Rituxan
Avonex
Betaseron
Rebif
FTY720
<

We can do it this way, but I think Avonex, Rebif, and Betaseron ought to be combined into a single answer choice because they are essentially the same drug.

Also, if the date to be used in the survey is 2010, that’s too soon for FTY720 to have any material impact.

Comments?